Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 3

2(33.3%)

Early Phase 1

1(16.7%)

6Total

N/A(3)

Phase 3(2)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06800248Phase 3Not Yet Recruiting

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

Role: collaborator

NCT07261254Not ApplicableRecruiting

Integrating Systems and Basic Income: Improving Outcomes for Families of Young Children

Role: collaborator

NCT06736691Phase 3Enrolling By Invitation

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

Role: collaborator

NCT06067555Early Phase 1Recruiting

Intradermal Influenza Vaccination

Role: collaborator

NCT06090916Not ApplicableActive Not Recruiting

Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer

Role: collaborator

NCT04218682Not ApplicableCompleted

Shadows Edge Mobile Developing Resilience in Adolescent and Young Adult Cancer Survivors

Role: collaborator

NCT03718845Completed

A Mind-Body Medicine Curriculum for Peer Counselors

Role: collaborator

All 7 trials loaded